Stocknews
FTSE Bursa Malaysia KLCI (^KLSE) 1,646.53 14.83 (0.90%)
updated at: Wed, 09 Dec 2020, 05:25PM MYT

Tag : DPHARMA

RHB Investment starts coverage on Duopharma Biotech, target price RM1.88 KUALA LUMPUR (Jan 8): RHB Investment Bank Bhd Research has initiated coverage on Duopharma Biotech Bhd with a "Buy" rating at RM1.58 and target price (TP) of RM...
Publish at Wed, 08 Jan 2020, 09:56AM
New plants expected to up capacity of Duopharma Biotech in 2021 Duopharma Biotech Bhd(Jan 8, RM1.54)Initiate coverage with buy and a target price (TP) of RM1.88:Our TP implies 20.1 times forecast financial year 2020 (FY20F)...
Publish at Thu, 09 Jan 2020, 10:42AM
Duopharma sales expected to grow on demand from consumer healthcare unit Duopharma Biotech Bhd(Jan 29, RM1.70)Downgrade to sell with an unchanged target price (TP) of RM1.70:Duopharma Biotech Bhd is unlikely to benefit from the influ...
Publish at Thu, 30 Jan 2020, 09:44AM
Duopharma posts higher net profit of RM55.27mil in FY19 Group managing director, Leonard Ariff Abdul Shatar, attributed the group’s strong performance to higher demand for the group’s pharmaceutical products from bot...
Publish at Thu, 13 Feb 2020, 06:50AM
Duopharma gets Govt contract extension, closes FY19 with higher profit KUALA LUMPUR (Feb 13): Duopharma Biotech Bhd, which has closed its financial year ended Dec 31, 2019 on a stronger footing despite a weaker fourth quarter, reve...
Publish at Thu, 13 Feb 2020, 08:16AM
末季跌全年净利升 联合药业派息5仙 （吉隆坡13日讯）尽管营业额增加，但由于成本走高，联合药业（Duopharma Biotech Bhd）第四季净利按年下跌16%。 该集团今日向大马交易所报备，截至去年12月杪2019财政年末...
Publish at Thu, 13 Feb 2020, 08:54AM
CGS-CIMB Research retains Add for Duopharma, lower TP of RM1.90 Duopharma Biotech’s FY19 revenue rose to RM576.5m (+15.6% yoy). FY19 core net profit grew 8.3% yoy to RM63m. This excluded one-off losses of RM7.8m from invento...
Publish at Fri, 14 Feb 2020, 08:58AM
Duopharma Biotech net profit up 16% to RM55.27mil Group managing director Leonard Ariff Abdul Shatar(pic) attributed the group’s strong performance to higher demand for the group’s pharmaceutical products from...
Publish at Fri, 14 Feb 2020, 10:00AM
Duopharma in talks for another contract extension Duopharma expansion
Publish at Mon, 24 Feb 2020, 07:40AM
【行家论股/视频】联合药业 盈利前景稳健 目标价：1.71令吉 最新进展 在2019冠状病毒病扩散之际，联合药业（DPHARMA，7148，主板保健股）管理层表明，目前供应没有中断，一些产品的销售有增长。 公司有信心赢得政府...
Publish at Tue, 17 Mar 2020, 08:00AM
Sales likely to grow for Duopharma in 2020 Duopharma Biotech Bhd(March 17, RM1.16)Upgrade to buy with an unchanged target price of RM1.71:On Covid-19, the management has seen a sales increase for some of...
Publish at Wed, 18 Mar 2020, 10:18AM
Duopharma Biotech's manufacturing activities to continue during movement control order period KUALA LUMPUR (March 18): Duopharma Biotech Bhd said all manufacturing activities at its sites in Klang, Bangi and Glenmarie will continue with extra precautions...
Publish at Wed, 18 Mar 2020, 03:04AM
【行家论股/视频】联合药业盈利前景稳健 目标价：1.71令吉 最新进展在2019冠状病毒病扩散之际，联合药业（DPHARMA，7148，主板保健股）管理层表明，目前供应没有中断，一些产品的销售有增长。公司有信心赢得政府红...
Publish at Tue, 17 Mar 2020, 12:00PM
Duopharma says there is no halt to its manufacturing ops KUALA LUMPUR: Duopharma Biotech Bhd has said that all manufacturing activities at its sites in Klang, Bangi, and Glenmarie will continue with extra precautions...
Publish at Thu, 19 Mar 2020, 09:48AM
联合药业上挑RM1.65/敏源 马股市在重量级蓝筹股项领跌之际，富时隆综指的交投走势持续高开低收。 综指于4月23日闭市时以1381.64报收，按日回退0.25点或0.02%，整日交投波幅介于16.56（1378.78-1395....
Publish at Fri, 24 Apr 2020, 12:11PM
Duopharma Biotech may rebound further, says RHB Retail Research KUALA LUMPUR (April 24): RHB Retail Research said Duopharma Biotech Bhd may rebound further after it tested the RM1.44 support in recent sessions. In a trading...
Publish at Fri, 24 Apr 2020, 08:14AM
兴业：联合药业可能进一步反弹 （吉隆坡24日讯）兴业零售研究指出，联合药业（Duopharma Biotech Bhd）在上一交易日测试1.44令吉支撑位后，可能会进一步反弹。 该研究机构今日在报告中表示，由于该股自4...
Publish at Fri, 24 Apr 2020, 09:27AM
Duopharma to invest over RM1m to boost digital health growth Group managing director Leonard Ariff Abdul Shatar Duopharma Biotech group managing director Leonard Ariff Abdul Shatar said one of the group’s primary strategi...
Publish at Fri, 24 Apr 2020, 04:01AM
Duopharma to get boost with bigger product range Duopharma Biotech Bhd 's corporate office
Publish at Tue, 12 May 2020, 08:50AM
Duopharma Biotech recommences operations KUALA LUMPUR (May 12): Duopharma Biotech Bhd's office and headquarters have recommenced operations, and will be open during ordinary business hours of the offic...
Publish at Tue, 12 May 2020, 02:45AM
Duopharma 1Q profit slides on forex loss due to stronger US dollar KUALA LUMPUR (May 18): Duopharma Biotech Bhd’s net profit slipped 6.25% to RM13.56 million for the first quarter ended March 31, 2020 (1QFY20), from RM14.47 mil...
Publish at Mon, 18 May 2020, 06:12AM
【全球大抗疫】联合药业首季净利跌6% （吉隆坡18日讯）受外汇亏损拖累，联合药业（DPHARMA，7148，主板保健股）截至3月底2020财年首季，净利年跌6.25%，报1356万1000令吉或每股赚1.98仙。 联合药业今天向马交所...
Publish at Mon, 18 May 2020, 08:40AM
Duopharma quarterly net profit at RM14mil According to its group managing director Leonard Ariff Abdul Shatar, (pic) the group’s improved revenue was due to higher demand for Duopharma’s pharmaceutical...
Publish at Tue, 19 May 2020, 08:20AM
UOB Kay Hian Research raises Duopharma target price “We continue to like Duopharma for its: a) leading position as a local producer but with ample areas of growth, particularly in the prescription market; b) effo...
Publish at Tue, 19 May 2020, 11:17AM
Vitamin C consumption bright spot for Duopharma during Covid-19 pandemic KUALA LUMPUR (May 19): The Covid-19 outbreak has caused many people to stock up on Vitamin C as they seek to boost immunity in the ongoing pandemic, and this is...
Publish at Tue, 19 May 2020, 11:54AM
值9106万·联合药业胰岛素合约延长 ●联合药业（DPHARMA,7148,主板医疗保健组）获得政府延长胰岛素供应合约，这项为期一年的合约价值达9106万令吉。 根据文告，该公司已与政府和Biocon公司签署附加合约，将供...
Publish at Fri, 22 May 2020, 09:35AM
联合药业9106万续政府约 （吉隆坡23日讯）政府延长联合药业（DPHARMA，7148，主板保健股）生物合成人胰岛素药品供应与运送合约1年，价值9106万令吉。 该公司日前向交易所报备，独资的Duopharma Mar...
Publish at Sun, 24 May 2020, 12:10PM
Duopharma looking to ride out the storm DUOPHARMA Biotech Bhd, which falls under the “essential services” category, was among the small group of companies that were given the leeway to operate during...
Publish at Wed, 03 Jun 2020, 04:00AM
联合药业韩联号公司上市 （吉隆坡17日讯）联合药业（DPHARMA，7148，主板保健股）韩国联号公司SCM Lifescience（简称SCML），今天在当地创业板（KOSDAQ）上市。 联合药业董事经理里奥纳阿里夫，今...
Publish at Wed, 17 Jun 2020, 04:48AM
Duopharma Biotech to expand consumer healthcare business KUALA LUMPUR (June 17): Duopharma Biotech Bhd said its strategies moving forward include expanding its consumer healthcare (CHC) product portfolio and diversify...
Publish at Wed, 17 Jun 2020, 05:48AM